Kalbe Farma Tbk PT
IDX:KLBF

Watchlist Manager
Kalbe Farma Tbk PT Logo
Kalbe Farma Tbk PT
IDX:KLBF
Watchlist
Price: 1 195 IDR
Market Cap: 55.9T IDR

Kalbe Farma Tbk PT
Other Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Kalbe Farma Tbk PT
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Kalbe Farma Tbk PT
IDX:KLBF
Other Current Liabilities
Rp1.2T
CAGR 3-Years
15%
CAGR 5-Years
5%
CAGR 10-Years
6%
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Other Current Liabilities
Rp381.4B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
11%
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Other Current Liabilities
Rp81.1B
CAGR 3-Years
20%
CAGR 5-Years
3%
CAGR 10-Years
4%
Soho Global Health Tbk PT
IDX:SOHO
Other Current Liabilities
Rp102B
CAGR 3-Years
-9%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Pyridam Farma Tbk PT
IDX:PYFA
Other Current Liabilities
Rp164B
CAGR 3-Years
74%
CAGR 5-Years
79%
CAGR 10-Years
47%
Kimia Farma Tbk PT
IDX:KAEF
Other Current Liabilities
Rp724B
CAGR 3-Years
42%
CAGR 5-Years
30%
CAGR 10-Years
25%
No Stocks Found

Kalbe Farma Tbk PT
Glance View

Kalbe Farma Tbk PT is a renowned pharmaceutical powerhouse rooted in Indonesia, rooted in a rich history that traces back to 1966. The company has evolved from a humble startup into a multifaceted entity with a robust portfolio, making it a vital player in the health and wellness sector across Southeast Asia. The company operates across four main business divisions: prescription pharmaceuticals, consumer health products, nutritionals, and distribution & logistics. By strategically linking these divisions, Kalbe Farma masterfully balances scientific innovation with market accessibility, ensuring a wide reach and varied product offering. This diversification not only broadens its revenue streams but also mitigates risk, securing its foothold in the competitive pharmaceutical landscape. At the core of Kalbe Farma’s business model lies a commitment to research and development, which fuels its cutting-edge product innovations and enhances its competitive edge. The company dedicates substantial resources to developing new medicines and health products, constantly seeking to address emerging health concerns. Moreover, its extensive distribution network fortifies its market presence, comprising a domestic distribution arm that penetrates even the farthest reaches of the Indonesian archipelago. This network ensures that Kalbe's products are widely available, amplifying their market penetration and revenue. Additionally, Kalbe embraces partnerships and collaborations to enhance its research capabilities and expand its product offerings, fostering an ecosystem where innovation and accessibility coexist harmoniously, thereby empowering its bottom line.

KLBF Intrinsic Value
HIDDEN
Show

See Also

What is Kalbe Farma Tbk PT's Other Current Liabilities?
Other Current Liabilities
1.2T IDR

Based on the financial report for Sep 30, 2025, Kalbe Farma Tbk PT's Other Current Liabilities amounts to 1.2T IDR.

What is Kalbe Farma Tbk PT's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
6%

Over the last year, the Other Current Liabilities growth was 26%. The average annual Other Current Liabilities growth rates for Kalbe Farma Tbk PT have been 15% over the past three years , 5% over the past five years , and 6% over the past ten years .

Back to Top